Clark Bishop is a Respiratory physician affiliated with Utah Valley Regional Medical Center. OpenAlex indexes 19 publications with 997 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
395 W Cougar Blvd
Provo, UT 846043311
Telephone
801-357-7291Provider last certified this registry record 5 Jun 2026.
Clinical trials
- Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients
Sponsor: Clark Bishop
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
62.9%Corticosteroid35.9%Trelegy Ellipta64%Symbicort15%Breo Ellipta10%Fluticasone Propionate10%Part D<11 patientsbeta2-Adrenergic Agonist18.2%Albuterol Sulfate Hfa100%Part D≥27 patients+ 2 more classes in this area
Anti-infectives
16.3%Tetracycline-class Drug7.2%Doxycycline Monohydrate100%Part D≥20 patientsMacrolide Antimicrobial6.3%Azithromycin100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
8.9%Kinase inhibitor6.1%Ofev100%Part D<11 patientsPyridone2.8%Pirfenidone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral Reduced L‐Glutathione Improves Growth in Pediatric Cystic Fibrosis Patients
Journal of Pediatric Gastroenterology and Nutrition
2015 - 62 Oral reduced L-glutathione improves weight and calprotectin in pediatric cystic fibrosis patients
Journal of Cystic Fibrosis
2013 - Improvement in clinical markers in CF patients using a reduced glutathione regimen: An uncontrolled, observational study
Journal of Cystic Fibrosis
2008 - Clinical course and spectrum of intensive care unit patients reactivating herpes simplex-1 virus: A retrospective analysis
Indian Journal of Critical Care Medicine
2008
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”